Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Zyleris PharmaTech

Zyleris offers high-throughput skin absorption and penetration screening service for topical formulation development using a proprietary high-throughput Franz Cell technology.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Zyleris PharmaTech
11 N. Skokie Highway, Suite G-16, Lake Bluff, IL, 60044, U.S.A
847-604-8474
Contact Zyleris PharmaTech
Website

 Latest Content from PMHub 

Did You Hear From Her? If Not Here’s What You Missed in Season 1 of the Award-Winning Season Podcast Series

Press Releases | February 15, 2024 | Medscape Education

What are some of the biggest gaps that women face in healthcare today?  “So many I could talk for hours!” said Shikha Jain, MD, FACP, President, CEO, Founder Women in Medicine....

Have you heard from her?

Press Releases | February 15, 2024 | Medscape Education

We’re referring to the renowned women leaders from across the healthcare landscape who were our guests on Season 1 of Medscape Education’s Hear From Her podcast series. The conversations touched...

Clinical trial considerations: Why diversity matters…

White Papers and Resources | February 15, 2024 | Cuttsy + Cuttsy

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Rare Disease Diagnostic Odyssey

Videos and Podcasts | February 14, 2024 | Medscape Education

Rare disease market access – Launching orphan drugs in secondary markets: the Nordic and MENA regions

Press Releases | February 14, 2024 | Petauri Evidence

Join us live at 1.00pm (GMT)/2.00pm (CET)/8.00am (EST) on Thursday 29th February, to explore rare disease market access challenges and learn more about these high potential markets.

The pitfalls of cutting costs on systematic literature reviews: 11 common issues to avoid

White Papers and Resources | February 14, 2024 | Petauri Evidence

Embarking on a systematic literature review is a critical step in evidence synthesis, providing a foundation for robust decision-making in the healthcare landscape. As with most things, there are ways...

Product launch: What market research when?

White Papers and Resources | February 14, 2024 | Inizio

Get the insights you need, when you need them, for your product launch planning

Clinical trial considerations: Why digital matters…

White Papers and Resources | February 14, 2024 | Cuttsy + Cuttsy

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Top-5 Trends in Virtual KOL Engagement

Press Releases | February 12, 2024 | Impetus Digital

Register now for one of our upcoming webinars (February 26-28)

Therapy Watch launches new tracker covering Alzheimer’s Disease

White Papers and Resources | February 12, 2024 | Inizio

The new Therapy Watch Alzheimer’s Disease tracker has recently launched in Germany, Japan and the US, with planned expansion into the remaining key European markets throughout 2024.